Acessibilidade

Marketing authorisation

Portugal as Reference Member State

Submission of Marketing Authorisation Applications

Submission of translations (Marketing Authorisation, Renewal and Variation procedures)

Publication of SmPCs and PLs in Infomed from clinical variations and renewals with Portugal as Concerned Member State

Publication of SmPCs and PLs in Infomed from clinical variations and renewals with Portugal as Concerned Member State - Correction

Template for revocation/withdrawal of marketing authorisation

MA revocation/ withdrawal request

Variations

Contact person for pharmacovigilance issues at national level

Homeopathic medicinal products

Points to Consider on non-clinical safety of homeopathic Medicinal Products of botanical, mineral and chemical origin for human use

Points to consider on safety of Homeopathic medicinal products of biological origin

Application form

Clinical trials

Qualified person declaration concerning investigational medicinal products manufactured in third countries

Statistics of Assessment of Clinical Trials

Pharmacovigilance

Questions and answers: Adverse Drug Reactions reporting

Training in EudraVigilance

Instructions to Applicants - Submission of Educational Materials

Instructions to Applicants - Submission of Direct Healthcare Professional Communication (DHPC)

Pharmacovigilance Bulletin

Inspections

Good Manufacturing Practices (GMP)

GMP Guidelines - EudraLex Volume 4

Good Laboratory Practices (GLP)

Note to Applicants for GLP Conformity Assessment

National GLP Compliance Monitoring Program

Portuguese Test Facilities in compliance with GLP

Reimbursement

Methodological Guidelines for Economic Evaluation Studies of Health Technologies

Observatory of Medicinal and Health Products

PPRI - Pharmaceutical Pricing & Reimbursement Information

ESAC - European Surveillance of Antimicrobial Consumption

Regulatory and scientific advice (RSA)

Simultaneous National Scientific Advice Pilot Project

Request for regulatory and scientific advice of medicinal products for human use

Guide for regulatory and scientific advice (RSA)

Guidance for applicants on Simultaneous National Scientific Advice (SNSA)

Expected Timeline SNSA

EU-Innovation Network Workplan 2024

Availability of medicines